These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35003106)

  • 21. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    Fernbach S; Mair NK; Abela IA; Groen K; Kuratli R; Lork M; Thorball CW; Bernasconi E; Filippidis P; Leuzinger K; Notter J; Rauch A; Hirsch HH; Huber M; Günthard HF; Fellay J; Kouyos RD; Hale BG;
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 39017930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19.
    Abers MS; Rosen LB; Delmonte OM; Shaw E; Bastard P; Imberti L; Quaresima V; Biondi A; Bonfanti P; Castagnoli R; Casanova JL; Su HC; Notarangelo LD; Holland SM; Lionakis MS
    Immunol Cell Biol; 2021 Oct; 99(9):917-921. PubMed ID: 34309902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
    Busnadiego I; Abela IA; Frey PM; Hofmaenner DA; Scheier TC; Schuepbach RA; Buehler PK; Brugger SD; Hale BG
    PLoS Biol; 2022 Jul; 20(7):e3001709. PubMed ID: 35788562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
    Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
    PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).
    Lee WI; Huang JL; Yeh KW; Jaing TH; Lin TY; Huang YC; Chiu CH
    J Formos Med Assoc; 2011 Dec; 110(12):750-8. PubMed ID: 22248828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.
    van der Wijst MGP; Vazquez SE; Hartoularos GC; Bastard P; Grant T; Bueno R; Lee DS; Greenland JR; Sun Y; Perez R; Ogorodnikov A; Ward A; Mann SA; Lynch KL; Yun C; Havlir DV; Chamie G; Marquez C; Greenhouse B; Lionakis MS; Norris PJ; Dumont LJ; Kelly K; Zhang P; Zhang Q; Gervais A; Le Voyer T; Whatley A; Si Y; Byrne A; Combes AJ; Rao AA; Song YS; Fragiadakis GK; Kangelaris K; Calfee CS; Erle DJ; Hendrickson C; Krummel MF; Woodruff PG; Langelier CR; Casanova JL; Derisi JL; Anderson MS; Ye CJ;
    Sci Transl Med; 2021 Sep; 13(612):eabh2624. PubMed ID: 34429372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-IFN-γ Immunodeficiency Syndrome Presenting as Blurred Vision and Salmonellosis.
    Peng SY; Chen TC; Wu UI; Huang CJ; Ho TC
    J Clin Immunol; 2021 Jan; 41(1):274-276. PubMed ID: 33155085
    [No Abstract]   [Full Text] [Related]  

  • 31. Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
    Hsieh HS; Gong YN; Chi CY; Hsieh SY; Chen WT; Ku CL; Cheng HT; Lin L; Sung CM
    Sci Rep; 2022 Jun; 12(1):9126. PubMed ID: 35650243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analysis.
    Wang X; Tang Q; Li H; Jiang H; Xu J; Bergquist R; Qin Z
    Int J Infect Dis; 2023 May; 130():147-152. PubMed ID: 36907547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.
    Hanitsch LG; Löbel M; Müller-Redetzky H; Schürmann M; Suttorp N; Unterwalder N; Mönnich U; Meisel C; Wittke K; Volk HD; Scheibenbogen C; Kölsch U
    J Clin Immunol; 2015 May; 35(4):361-5. PubMed ID: 25875701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
    Manry J; Bastard P; Gervais A; Le Voyer T; Rosain J; Philippot Q; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; de Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Mégarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs CM; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; van de Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A; Kann NY; Shcherbina A; Lau YL; Leung D; Coulongeat M; Marlet J; Koning R; Reyes LF; Chauvineau-Grenier A; Venet F; Monneret G; Nussenzweig MC; Arrestier R; Boudhabhay I; Baris-Feldman H; Hagin D; Wauters J; Meyts I; Dyer AH; Kennelly SP; Bourke NM; Halwani R; Sharif-Askari FS; Dorgham K; Sallette J; Sedkaoui SM; AlKhater S; Rigo-Bonnin R; Morandeira F; Roussel L; Vinh DC; Erikstrup C; Condino-Neto A; Prando C; Bondarenko A; Spaan AN; Gilardin L; Fellay J; Lyonnet S; Bilguvar K; Lifton RP; Mane S; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Anderson MS; Boisson B; Béziat V; Zhang SY; Andreakos E; Hermine O; Pujol A; Peterson P; Mogensen TH; Rowen L; Mond J; Debette S; de Lamballerie X; Burdet C; Bouadma L; Zins M; Soler-Palacin P; Colobran R; Gorochov G; Solanich X; Susen S; Martinez-Picado J; Raoult D; Vasse M; Gregersen PK; Piemonti L; Rodríguez-Gallego C; Notarangelo LD; Su HC; Kisand K; Okada S; Puel A; Jouanguy E; Rice CM; Tiberghien P; Zhang Q; Casanova JL; Abel L; Cobat A
    Proc Natl Acad Sci U S A; 2022 May; 119(21):e2200413119. PubMed ID: 35576468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Examination of autoantibodies to type I interferon in patients suffering from long COVID.
    Hansen KS; Jørgensen SE; Skouboe MK; Agergaard J; Schiøttz-Christensen B; Vibholm LK; Tolstrup M; Østergaard L; Leth S; Mogensen TH
    J Med Virol; 2023 Sep; 95(9):e29089. PubMed ID: 37698062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dot enzyme-linked immunosorbent assay strip as a screening tool for detection of autoantibody to interferon gamma in sera of suspected cases of adult-onset immunodeficiency.
    Rattanathammethee K; Chawansuntati K; Chaiwarith R; Praparattanapan J; Supparatpinyo K; Wipasa J
    J Clin Lab Anal; 2018 Sep; 32(7):e22460. PubMed ID: 29682788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.
    Chen ZM; Li ZT; Li SQ; Guan WJ; Qiu Y; Lei ZY; Zhan YQ; Zhou H; Lin S; Wang X; Li Z; Yang F; Zeng W; Lin Y; Liu J; Zhang JQ; Ye F
    BMC Infect Dis; 2021 Jun; 21(1):587. PubMed ID: 34144700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticytokine autoantibody-associated immunodeficiency.
    Browne SK
    Annu Rev Immunol; 2014; 32():635-57. PubMed ID: 24499273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adult-onset immunodeficiency mediated by anti-IFN-γ autoantibody combined with disseminated mycobacterium marseillense infection: a case report].
    Liu JJ; Qin L; Cong Y; Liu HT; Fan JP; Fan HW; Zhou BT; Cao W
    Zhonghua Nei Ke Za Zhi; 2024 Aug; 63(8):795-799. PubMed ID: 39069870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.